-
公开(公告)号:US20110185581A1
公开(公告)日:2011-08-04
申请号:US12835393
申请日:2010-07-13
申请人: Li Xing , Yibao Zhang , Feng Zhang
发明人: Li Xing , Yibao Zhang , Feng Zhang
摘要: A circular saw includes a housing, a motor having a rotating axis and a center of gravity on the rotating axis, a handle, a circular blade, a fixed guard, and a base plate having a width supporting the housing. The motor and the circular blade are parallel or coplanar with respect to each other and the circular saw does not extend beyond the width of the base plate in the width direction.
摘要翻译: 圆锯包括壳体,具有旋转轴线的旋转轴线和重心在旋转轴上的电机,手柄,圆形刀片,固定护罩和具有支撑壳体的宽度的底板。 马达和圆形刀片相对于彼此平行或共面,并且圆锯不延伸超过基板在宽度方向上的宽度。
-
2.MULTIPLE ANTIGEN DELIVERY SYSTEM USING HEPATITIS E VIRUS-LIKE PARTICLE 审中-公开
标题翻译: 使用乙型肝炎病毒颗粒的多种抗原递送系统公开(公告)号:US20120064169A1
公开(公告)日:2012-03-15
申请号:US13220356
申请日:2011-08-29
申请人: R. Holland Cheng , Li Xing , Tatsuo Miyamura , Yasuhiro Yasutomi , Tian-Cheng Li , Naokazu Takeda
发明人: R. Holland Cheng , Li Xing , Tatsuo Miyamura , Yasuhiro Yasutomi , Tian-Cheng Li , Naokazu Takeda
CPC分类号: A61K39/21 , A61K39/12 , A61K39/29 , A61K2039/5258 , A61K2039/541 , A61K2039/542 , C07K14/005 , C07K2319/40 , C12N2740/16122 , C12N2740/16134 , C12N2740/16234 , C12N2770/28123 , C12N2770/28134 , C12N2770/28142
摘要: This invention provides a peptide/nucleic acid composition for oral/mucosal, dual-modal activation of immune protection systems.
摘要翻译: 本发明提供了用于免疫保护系统的口腔/粘膜,双重模态激活的肽/核酸组合物。
-
3.Process and apparatus for producing hydrocarbons from residential trash or waste and/or organic waste materials 失效
标题翻译: 从住宅垃圾或废物和/或有机废物生产碳氢化合物的工艺和设备公开(公告)号:US06133491A
公开(公告)日:2000-10-17
申请号:US204078
申请日:1998-12-03
申请人: Li Xing
发明人: Li Xing
CPC分类号: C10G1/02 , C10B47/30 , C10G1/08 , F23G5/20 , F23G2203/211
摘要: The invention provides a process and apparatus for producing hydrocarbons from residential trash or waste and/or organic waste materials. In particular, the invention provides a process and apparatus for producing hydrocarbons from residential trash or waste and/or organic waste materials in virtue of pyrolysis and catalytic cracking.
摘要翻译: 本发明提供了一种用于从住宅垃圾或废物和/或有机废物生产碳氢化合物的方法和装置。 特别地,本发明提供了由于热解和催化裂化而从住宅垃圾或废物和/或有机废物生产碳氢化合物的方法和装置。
-
4.PROTEOLYSIS-RESISTANT CAPSID OF CHIMERIC HEPATITIS E VIRUS AS AN ORAL DELIVERY VECTOR 有权
标题翻译: 作为口服递送载体的重型乙型肝炎病毒的抗肿瘤药物公开(公告)号:US20120301494A1
公开(公告)日:2012-11-29
申请号:US13224151
申请日:2011-09-01
申请人: R. Holland Cheng , Li Xing
发明人: R. Holland Cheng , Li Xing
CPC分类号: C07K14/005 , A61K9/5184 , A61K39/00 , A61K39/12 , A61K39/21 , A61K39/29 , A61K2039/5258 , A61K2039/53 , A61K2039/541 , A61K2039/542 , C07K16/10 , C07K16/1063 , C07K2317/34 , C07K2317/55 , C07K2317/76 , C07K2319/00 , C07K2319/40 , C12N7/00 , C12N2710/14143 , C12N2740/16122 , C12N2740/16134 , C12N2740/16234 , C12N2770/28123 , C12N2770/28134 , C12N2770/28142
摘要: This invention provides a peptide/nucleic acid composition for oral/mucosal, dual-modal activation of immune protection systems.
摘要翻译: 本发明提供了用于免疫保护系统的口腔/粘膜,双重模态激活的肽/核酸组合物。
-
公开(公告)号:US20070088033A1
公开(公告)日:2007-04-19
申请号:US11531492
申请日:2006-09-13
申请人: Balekudru Devadas , John Walker , Shaun Selness , Terri Boehm , Richard Durley , Rajesh Devraj , Brian Hickory , Paul Rucker , Kevin Jerome , Heather Madsen , Edgardo Alvira , Michele Promo , Radhika Blevis-Bal , Laura Marruto , Jeff Hitchcock , Thomas Owen , Win Naing , Li Xing , Huey Shieh , Aruna Sambandam , Shuang Liu , Ian Scott , Kevin McGee
发明人: Balekudru Devadas , John Walker , Shaun Selness , Terri Boehm , Richard Durley , Rajesh Devraj , Brian Hickory , Paul Rucker , Kevin Jerome , Heather Madsen , Edgardo Alvira , Michele Promo , Radhika Blevis-Bal , Laura Marruto , Jeff Hitchcock , Thomas Owen , Win Naing , Li Xing , Huey Shieh , Aruna Sambandam , Shuang Liu , Ian Scott , Kevin McGee
IPC分类号: A61K31/53 , A61K31/506 , A61K31/497 , A61K31/4439 , A61K31/4545 , A61K31/4709 , C07D417/02 , C07D403/02 , C07D401/02
CPC分类号: C07D213/64 , C07D213/69 , C07D213/70 , C07D213/74 , C07D213/75 , C07D213/79 , C07D213/84 , C07D213/85 , C07D215/22 , C07D401/04 , C07D401/06 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/06 , C07D409/14 , C07D413/10
摘要: Disclosed are compounds Formula I and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and R5 are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase and/or TNF activity. Pharmaceutical compositions containing the compounds, methods of preparing the compounds and methods of treatment using the compounds are also disclosed.
摘要翻译: 公开了式I化合物及其药学上可接受的盐,其中R 1,R 2,R 3,R 4, >和R 5>在本文中定义。 这些化合物可用于治疗由不受调节的p38 MAP激酶和/或TNF活性引起或加重的疾病和病症。 还公开了含有化合物的药物组合物,制备化合物的方法和使用该化合物的治疗方法。
-
公开(公告)号:US20060211694A1
公开(公告)日:2006-09-21
申请号:US11226556
申请日:2005-09-14
申请人: Balekudru Devadas , John Walker , Shaun Selness , Terri Boehm , Richard Durley , Rajesh Devraj , Brian Hickory , Paul Rucker , Kevin Jerome , Heather Madsen , Edgardo Alvira , Michele Promo , Radhika Blevis-Bal , Laura Marruto , Jeff Hitchcock , Thomas Owen , Win Naing , Li Xing , Huey Shieh , Aruna Sambandam , Shuang Liu , Ian Scott , Kevin McGee
发明人: Balekudru Devadas , John Walker , Shaun Selness , Terri Boehm , Richard Durley , Rajesh Devraj , Brian Hickory , Paul Rucker , Kevin Jerome , Heather Madsen , Edgardo Alvira , Michele Promo , Radhika Blevis-Bal , Laura Marruto , Jeff Hitchcock , Thomas Owen , Win Naing , Li Xing , Huey Shieh , Aruna Sambandam , Shuang Liu , Ian Scott , Kevin McGee
IPC分类号: A61K31/53 , A61K31/506 , A61K31/498 , A61K31/497 , A61K31/501 , A61K31/4439 , A61K31/4747 , A61K31/4709 , A61K31/4412
CPC分类号: C07D213/64 , C07D213/69 , C07D213/70 , C07D213/74 , C07D213/75 , C07D213/79 , C07D213/84 , C07D213/85 , C07D215/22 , C07D401/04 , C07D401/06 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/06 , C07D409/14 , C07D413/10
摘要: Disclosed are compounds Formula I and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and R5 are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase and/or TNF activity. Pharmaceutical compositions containing the compounds, methods of preparing the compounds and methods of treatment using the compounds are also disclosed.
摘要翻译: 公开了式I化合物及其药学上可接受的盐,其中R 1,R 2,R 3,R 4, >和R 5>在本文中定义。 这些化合物可用于治疗由不受调节的p38 MAP激酶和/或TNF活性引起或加重的疾病和病症。 还公开了含有化合物的药物组合物,制备化合物的方法和使用该化合物的治疗方法。
-
公开(公告)号:US07067540B2
公开(公告)日:2006-06-27
申请号:US10367987
申请日:2003-02-14
申请人: Balekudru Devadas , John Walker , Shaun R. Selness , Terri L. Boehm , Richard C. Durley , Rajesh Devraj , Brian S. Hickory , Paul V. Rucker , Kevin D. Jerome , Heather M. Madsen , Edgardo Alvira , Michele A. Promo , Radhika M. Blevis-Bal , Laura D. Marruto , Jeff Hitchcock , Thomas Owen , Win Naing , Li Xing , Huey S. Shieh , Aruna Sambandam , Shuang Liu , Ian L. Scott , Kevin F. McGee
发明人: Balekudru Devadas , John Walker , Shaun R. Selness , Terri L. Boehm , Richard C. Durley , Rajesh Devraj , Brian S. Hickory , Paul V. Rucker , Kevin D. Jerome , Heather M. Madsen , Edgardo Alvira , Michele A. Promo , Radhika M. Blevis-Bal , Laura D. Marruto , Jeff Hitchcock , Thomas Owen , Win Naing , Li Xing , Huey S. Shieh , Aruna Sambandam , Shuang Liu , Ian L. Scott , Kevin F. McGee
IPC分类号: A61K31/44 , C07D213/02 , C07D401/02
CPC分类号: C07D213/64 , C07D213/69 , C07D213/70 , C07D213/74 , C07D213/75 , C07D213/79 , C07D213/84 , C07D213/85 , C07D215/22 , C07D401/04 , C07D401/06 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/06 , C07D409/14 , C07D413/10
摘要: Disclosed are compounds Formula I and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and R5 are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase and/or TNF activity. Pharmaceutical compositions containing the compounds, methods of preparing the compounds and methods of treatment using the compounds are also disclosed.
摘要翻译: 公开了式I化合物及其药学上可接受的盐,其中R 1,R 2,R 3,R 4, >和R 5>在本文中定义。 这些化合物可用于治疗由不受调节的p38 MAP激酶和/或TNF活性引起或加重的疾病和病症。 还公开了含有化合物的药物组合物,制备化合物的方法和使用该化合物的治疗方法。
-
公开(公告)号:US20050176775A1
公开(公告)日:2005-08-11
申请号:US10918826
申请日:2004-08-13
申请人: Balekudru Devadas , John Walker , Shaun Selness , Terri Boehm , Richard Durley , Rajesh Devraj , Brian Hickory , Paul Rucker , Kevin Jerome , Heather Madsen , Edgardo Alvira , Michele Promo , Radhika Blevis-Bal , Laura Marrufo , Jeff Hitchcock , Thomas Owen , Win Naing , Li Xing , Huey Shieh , Aruna Sambandam , Shuang Liu , Ian Scott , Kevin McGee
发明人: Balekudru Devadas , John Walker , Shaun Selness , Terri Boehm , Richard Durley , Rajesh Devraj , Brian Hickory , Paul Rucker , Kevin Jerome , Heather Madsen , Edgardo Alvira , Michele Promo , Radhika Blevis-Bal , Laura Marrufo , Jeff Hitchcock , Thomas Owen , Win Naing , Li Xing , Huey Shieh , Aruna Sambandam , Shuang Liu , Ian Scott , Kevin McGee
IPC分类号: A61K20060101 , A61K31/4412 , A61K31/4415 , A61K31/4439 , A61P29/00 , C07D211/86 , C07D213/64 , C07D213/69 , C07D213/70 , C07D213/73 , C07D213/74 , C07D213/75 , C07D213/80 , C07D213/84 , C07D215/22 , C07D401/04 , C07D401/06 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/06 , C07D409/12 , C07D409/14 , C07D413/06 , C07D413/10 , C07D417/04 , C07D41/02
CPC分类号: C07D213/69 , C04B35/632 , C07D213/64 , C07D213/70 , C07D213/73 , C07D213/80 , C07D215/22 , C07D401/04 , C07D401/06 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/06 , C07D409/12 , C07D409/14 , C07D413/06 , C07D413/10 , C07D417/04
摘要: Disclosed are compounds of Formula I and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and R5 are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase and/or TNF activity. Pharmaceutical compositions containing the compounds, methods of preparing the compounds and methods of treatment using the compounds are also disclosed.
摘要翻译: 公开了式I的化合物及其药学上可接受的盐,其中R 1,R 2,R 3,R 4, SUB>和R 5>在本文中定义。 这些化合物可用于治疗由不受调节的p38 MAP激酶和/或TNF活性引起或加重的疾病和病症。 还公开了含有化合物的药物组合物,制备化合物的方法和使用该化合物的治疗方法。
-
9.Multiple antigen delivery system using hepatitis E virus-like particle 有权
标题翻译: 使用戊型肝炎病毒样颗粒的多重抗原递送系统公开(公告)号:US08906862B2
公开(公告)日:2014-12-09
申请号:US13220356
申请日:2011-08-29
申请人: R. Holland Cheng , Li Xing , Tatsuo Miyamura , Yasuhiro Yasutomi , Tian-Cheng Li , Naokazu Takeda
发明人: R. Holland Cheng , Li Xing , Tatsuo Miyamura , Yasuhiro Yasutomi , Tian-Cheng Li , Naokazu Takeda
IPC分类号: A61K38/16 , C07K14/005 , A61K39/29 , A61K39/21 , A61K39/00
CPC分类号: A61K39/21 , A61K39/12 , A61K39/29 , A61K2039/5258 , A61K2039/541 , A61K2039/542 , C07K14/005 , C07K2319/40 , C12N2740/16122 , C12N2740/16134 , C12N2740/16234 , C12N2770/28123 , C12N2770/28134 , C12N2770/28142
摘要: This invention provides a peptide/nucleic acid composition for oral/mucosal, dual-modal activation of immune protection systems.
摘要翻译: 本发明提供了用于免疫保护系统的口腔/粘膜,双重模态激活的肽/核酸组合物。
-
公开(公告)号:US20120060665A1
公开(公告)日:2012-03-15
申请号:US13218016
申请日:2011-08-25
申请人: Li Xing , Wei Dai , Shaojun Wang
发明人: Li Xing , Wei Dai , Shaojun Wang
IPC分类号: B23D59/00
CPC分类号: B23D59/00 , B25H1/0078 , Y10T83/8763 , Y10T83/8878
摘要: A guiding mechanism for an electric tool includes at least two guiding elements at least one of which has a first end portion having at least one protruding portion extending outwards therefrom and the other of which has a second end portion having at least one groove therein which may be engaged with the protruding portion. The groove has a cut-out and the protruding portion has an elastic clamping portion which may be engaged with the cut-out.
摘要翻译: 电动工具的引导机构包括至少两个引导元件,其中至少一个引导元件具有第一端部部分,该第一端部部分具有从其向外延伸的至少一个突出部分,另一个引导元件具有第二端部,其中至少一个凹槽 与突出部分接合。 凹槽具有切口,并且突出部分具有可与切口接合的弹性夹持部分。
-
-
-
-
-
-
-
-
-